Castleview Partners, LLC Veracyte, Inc. Transaction History
Castleview Partners, LLC
- $151 Million
- Q4 2024
A detailed history of Castleview Partners, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Castleview Partners, LLC holds 2,268 shares of VCYT stock, worth $103,148. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,268
Previous 2,550
11.06%
Holding current value
$103,148
Previous $100,000
11.0%
% of portfolio
0.06%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
313Shares Held
81.7MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$354 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$352 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$228 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$224 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$193 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.26B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...